How did Intuitive Surgical's revenue perform in the second quarter of 2015 compared to the prior year?

Intuitive Surgical reported a 14% increase in total revenue for the three months ended June 30, 2015, reaching $586.1 million, up from $512.2 million in the same period of 2014. This growth was driven by increases in both system revenue (up 22%) and recurring revenue from instruments, accessories, and services (up 13% for instruments/accessories and 6% for services).

What is the current status of the company's product liability litigation?

The company is facing approximately 101 individual product liability lawsuits and a multi-plaintiff lawsuit related to alleged injuries from da Vinci Surgical System use. While the company denies liability, it recorded pre-tax charges of $6.6 million in Q2 2015 and $13.8 million for the six months ended June 30, 2015, related to the estimated cost of settling some of these claims. The ultimate outcome remains uncertain and could materially impact future results, though the company does not currently estimate a material adverse effect.

How is the launch of the da Vinci Xi Surgical System impacting the company?

The da Vinci Xi Surgical System, launched in Q2 2014, is seeing a favorable market response. System revenue increased significantly, with 118 da Vinci Surgical Systems shipped in Q2 2015 compared to 96 in Q2 2014. The Xi system is part of the company's strategy to offer a broader line of systems to meet diverse hospital needs, and its introduction is contributing to overall revenue growth, although newer products like the Xi system initially have lower gross margins.

What is the company's financial position regarding cash and investments?

Intuitive Surgical maintained a strong liquidity position, with cash, cash equivalents, and investments totaling $2.9 billion as of June 30, 2015. This represents an increase from $2.5 billion at the end of 2014, primarily fueled by positive cash flow from operations. The company believes its current financial resources are sufficient to meet its liquidity requirements for the foreseeable future.

ISRG 10-Q Quarterly Report Q2 FY2015 — Revenue, Net Income, EPS

Summary

Intuitive Surgical, Inc. (ISRG) reported strong financial results for the period ending June 29, 2015. Total revenue for the second quarter of 2015 increased by 14% year-over-year to $586.1 million, driven by robust growth in both system and recurring revenue streams. Specifically, system revenue saw a 22% increase, and instruments and accessories revenue grew by 13%. This top-line growth translated into a significant improvement in profitability, with operating income rising by 22% to $173.8 million. The company's installed base of da Vinci Surgical Systems continued to expand, reaching approximately 3,398 units globally. Procedure volume also saw healthy growth, increasing by 14% in the second quarter, indicating continued adoption and utilization of their robotic surgical systems. Despite some headwinds from foreign currency fluctuations and ongoing legal matters, Intuitive Surgical demonstrated solid operational execution and financial strength, reinforcing its market leadership in robotic-assisted surgery.

Financial Highlights

46 data points

Beta

Revenue

$586.10M

0.7% Gross Margin

Net Income

$134.50M

0.2% Net Margin

EPS (Diluted)

$0.40

Total Assets

$4.35B

Cash & Equivalents

$915.40M

Free Cash Flow

$185.10M

Financial Statements

Beta

Revenue	$586.10M
Cost of Revenue	$199.60M
Gross Profit	$386.50M
R&D Expenses	$49.40M
SG&A Expenses	$163.30M
Operating Expenses	$212.70M
Operating Income	$173.80M
Net Income	$134.50M
EPS (Basic)	$0.40
EPS (Diluted)	$0.40
Shares Outstanding (Basic)	332.10M
Shares Outstanding (Diluted)	340.20M

Key Highlights

1Total revenue increased 14% to $586.1 million in Q2 2015 compared to Q2 2014.
2Systems revenue grew 22% year-over-year, indicating strong demand for da Vinci Surgical Systems.
3Instruments and accessories revenue, a key recurring revenue driver, increased by 13%.
4Operating income rose 22% to $173.8 million, demonstrating improved profitability.
5The installed base of da Vinci Surgical Systems expanded to approximately 3,398 units.
6Global da Vinci procedure volume increased by 14% in Q2 2015, signaling continued adoption.
7The company ended the period with a strong cash position of $2.9 billion in cash, cash equivalents, and investments.

INTUITIVE SURGICAL INC Quarterly Report for Q2 Ended Jun 30, 2015

Summary

Financial Highlights

Key Highlights

Frequently Asked Questions